Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.

World journal of gastroenterology - 7 Nov 2016

Chackelevicius Carla Melisa, Gambaro Sabrina Eliana, Tiribelli Claudio, Rosso Natalia

Abstract excerpt

The nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD encompasses a wide histological spectrum ranging from benign simple steatosis to non-alcoholic steatohepatitis (NASH). Sustained inflammation in the liver is critical in this process. Hepatic macrophages, including liver resident macropaghes (Kupffer cells), monocytes infiltrating the injured liver, as well...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Differentiation
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Inflammation Mediators

Share to Lymphocyte Activation

Share to Non-alcoholic Fatty Liver Disease

Share to Th17 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 27895397
DOI: 10.3748/wjg.v22.i41.9096
PMCID: PMC5107591

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.PMID 27895397Read ↗

The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications.Semantic proximity Read ↗

Pathogenesis of nonalcoholic steatohepatitis.Semantic proximity Read ↗

Myeloid cells contribute to bystander CD8 T cell accumulation in metabolic-associated steatohepatitis and are sufficient for fibrosisSemantic proximity Read ↗

Immunological liver-skin axis: a systemic Vγ4 <sup>+</sup> γδT17 cell response links psoriasis-like inflammation and MASLDSemantic proximity Read ↗

Macrophage Polarization and Its Role in Liver Disease.Semantic proximity Read ↗

Ambiguous Pathogenic Roles of Macrophages in Alcohol-Associated Liver DiseasesSemantic proximity Read ↗

Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse.Semantic proximity Read ↗

Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarizationSemantic proximity Read ↗

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH.Semantic proximity Read ↗

Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis.Semantic proximity Read ↗

Macrophage Phenotype and Function in Liver Disorder.Semantic proximity Read ↗

Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.